Targeting type VII/ESX secretion systems for development of novel antimycobacterial drugs. Curr Pharm Des. 2014; 20: 4346-56. PMID: 24245757Bottai D, Serafini A, Cascioferro A, Brosch R & Manganelli R (2014) Targeting type VII/ESX secretion systems for development of novel antimycobacterial ...
Jeffrey M Chen,,Florence P, et al.Towards anti-virulence drugs targeting ESX-1 mediated pathogenesis of Mycobacterium tuberculosis. Dru Dis Tod Dis Mechan . 2010Chen JM, Pojer F, Blasco B, Cole ST (2010) Towards anti-virulence drugs targeting ESX-1 mediated pathogenesis of Mycobacterium ...
Towards anti-virulence drugs targeting ESX-1 mediated pathogenesis of Mycobacterium tuberculosis[J] . Jeffrey M. Chen,Florence Pojer,Benjamin Blasco,Stewart T. Cole.Drug Discovery Today: Disease Mechanisms . 2010 (1)Chen, J. M.; Pojer, F.; Blasco, B.; Cole, S. T. Towards anti- ...